Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cogentix Medical (CGNT) Share Price

News articles about Cogentix Medical (NASDAQ:CGNT) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cogentix Medical earned a news sentiment score of 0.07 on Accern’s scale. Accern also assigned media coverage about the medical device company an impact score of 45.3754559921726 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Cogentix Medical (CGNT) traded up $0.01 during mid-day trading on Thursday, reaching $2.90. 76,800 shares of the company traded hands, compared to its average volume of 63,599. Cogentix Medical has a 52 week low of $1.55 and a 52 week high of $3.26.

CGNT has been the topic of a number of recent research reports. JMP Securities initiated coverage on shares of Cogentix Medical in a research note on Friday, October 6th. They set an “outperform” rating and a $5.00 price target on the stock. Roth Capital initiated coverage on shares of Cogentix Medical in a research note on Wednesday, November 8th. They set a “buy” rating and a $4.00 price target on the stock. Zacks Investment Research downgraded shares of Cogentix Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Aegis began coverage on shares of Cogentix Medical in a research note on Friday, December 1st. They set a “buy” rating and a $4.75 price target on the stock. Finally, TheStreet raised shares of Cogentix Medical from a “d+” rating to a “c” rating in a research note on Thursday, November 9th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. Cogentix Medical has a consensus rating of “Buy” and a consensus target price of $4.06.

ILLEGAL ACTIVITY WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cogentix Medical (CGNT) Share Price” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was stolen and reposted in violation of United States and international trademark and copyright law. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/14/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-cogentix-medical-cgnt-share-price.html.

Cogentix Medical Company Profile

Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).

Insider Buying and Selling by Quarter for Cogentix Medical (NASDAQ:CGNT)

Receive News & Ratings for Cogentix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply